Q3 2024 Earnings Conference Call October 31, 2024 8:00 AM ET. Company Participants. Bryan Dunn – Head of Investor Relations Will Lewis – Chai ...

Eosinophilic asthma (also known as e-asthma or eos asthma) is a severe form of asthma that causes high levels of eosinophils in the lung tissue, blood, and mucus. Eosinophils are a type of immune ...

Total Revenue of $93.4 Million for the Third Quarter of 2024, Reflecting 18% Growth Over the Third Quarter of 2023? ?NDA Submission for Brensocatib in Bronchiectasis Remains on Track for the ...